Stay updated with breaking news from Conversion Labs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
LifeMD (NASDAQ:LFMD – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued on Wednesday, Zacks.com reports. According to Zacks, “LifeMD Inc. is a telehealth company. It offers a full portfolio of direct-to-patient products and services. The company combines virtual medical treatment with prescription […]
Liquid meth is coming over there are conversion labs all over our country, too. >> trace: you put up all the pictures of the kids that have died of overdoses and i want to put these numbers on the screen because i find this kind of astounding. in 2018 they found 1 pound of fentanyl. in 2019, 2 pounds. look at 2021 so far, we have six months left in the year. 41 pounds and it's important to point out that 2 milligrams of fentanyl can be lethal. if 41 pounds was found, how much got in? >> first of all, cbp does a great job at statistics. this year so far 7450 pounds of fentanyl has been seized a...
Share this article Share this article NEW YORK, May 25, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against LifeMD, Inc. f/k/a Conversion Labs, Inc. ("LifeMD" or the "Company") (NASDAQ: LFMD) and certain of its officers. The class action, filed in the United States District Court for the Southern District of New York, and docketed under 21-cv-04004, is on behalf of a class consisting of all persons and entities other than Defendants who purchased or otherwise acquired LifeMD securities between January 19, 2021 and April 13, 2021, inclusive (the...
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in LifeMD, Inc. f/k/a Conversion Labs, Inc. of Class Action Lawsuit and Upcoming Deadline – LFMD Home / Top News / SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in LifeMD, Inc. f/k/a Conversion Labs, Inc. of Class Action Lawsuit and Upcoming Deadline – LFMD SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in LifeMD, Inc. f/k/a Conversion Labs, Inc. of Class Action Lawsuit and Upcoming Deadline – LFMD NEW YORK, M...
Share this article Share this article NEW YORK, May 11, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against LifeMD, Inc. f/k/a Conversion Labs, Inc. ("LifeMD" or the "Company") (NASDAQ: LFMD) and certain of its officers. The class action, filed in the United States District Court for the Southern District of New York, and docketed under 21-cv-04004, is on behalf of a class consisting of all persons and entities other than Defendants who purchased or otherwise acquired LifeMD securities between January 19, 2021 and April 13, 2021, inclusive (the ...